The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
Abstract
There is still no cure for inflammatory bowel disease. This review covers newer treatments that reflect our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more precise molecular targeting of inflammatory cascades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From molecular to modular cell biology.
Hartwell, L. H., Hopfield, J. J., Leibler, S., & Murray, A. W. (1999) · Nature · doi:10.1038/35011540 · Cited by 3,632
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Bernardo, M. E., & Fibbe, W. E. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.006 · Cited by 1,383
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz180 · Cited by 1,374
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Sands, B. E., Sandborn, W. J., Panaccione, R., O’Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van Assche, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900750 · Cited by 1,219
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31203-x · Cited by 1,092
Self-citationPanaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Colombel, J.-F., Panaccione, R., Bossuyt, P., Lukas, M., Baert, F., Vaňásek, T., Danalioglu, A., Novacek, G., Armuzzi, A., Hébuterne, X., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32641-7 · Cited by 921
Martin, J. C., Chang, C., Boschetti, G., Ungaro, R., Giri, M., Grout, J. A., Gettler, K., Chuang, L.-S., Nayar, S., Greenstein, A. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.008 · Cited by 872
Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., Katsikeros, R., Makanyanga, J., Campaniello, M. A., Mavrangelos, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20046 · Cited by 842
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Colombel, J.-F., Sands, B. E., Rutgeerts, P., Sandborn, W., Danese, S., D'Haens, G., Panaccione, R., Loftus, E. V., Sankoh, S., Fox, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311079 · Cited by 806
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Pathway paradigms revealed from the genetics of inflammatory bowel disease
Graham, D. B., & Xavier, R. J. (2020) · Nature · doi:10.1038/s41586-020-2025-2 · Cited by 771
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands, B. E., Peyrin-Biroulet, L., Loftus, E. V., Danese, S., Colombel, J.-F., Törüner, M., Jonaitis, L., Abhyankar, B., Chen, J., Rogers, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905725 · Cited by 754
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Feuerstein, J. D., Isaacs, K. L., Schneider, Y., Siddique, S. M., Falck-Ytter, Y., Singh, S., Chachu, K., Day, L., Lebwohl, B., Muniraj, T., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.006 · Cited by 713
Kennedy, N. A., Heap, G. A., Green, H. D., Hamilton, B., Bewshea, C., Walker, G. J., Thomas, A., Nice, R., Perry, M. H., Bouri, S., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30012-3 · Cited by 691
Cancers Complicating Inflammatory Bowel Disease
Beaugerie, L., & Itzkowitz, S. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403718 · Cited by 678
Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.021 · Cited by 671
Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Nachury, M., Moreau, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61084-8 · Cited by 646
Louis, E., Mary, J., Vernier–Massouille, G., Grimaud, J., Bouhnik, Y., Laharie, D., Dupas, J., Pillant, H., Picon, L., Veyrac, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.034 · Cited by 597
Lemaitre, M., Kirchgesner, J., Rudnichi, A., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2017) · JAMA · doi:10.1001/jama.2017.16071 · Cited by 575
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., D’Haens, G., Wolf, D. C., Jovanovic, I., Hanauer, S. B., Ghosh, S., Petersen, A., Hua, S. Y., Lee, J. H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033617 · Cited by 569
Rutgeerts, P., Diamond, R. H., Bala, M., Olson, A., Lichtenstein, G. R., Bao, W., Patel, K., Wolf, D. C., Safdi, M., Colombel, J. F., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.011 · Cited by 548
Sim, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806949 · Cited by 491
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.020 · Cited by 483
Self-citationThe Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
Feagan, B. G., Danese, S., Loftus, E. V., Vermeire, S., Schreiber, S., Ritter, T., Fogel, R., Mehta, R., Nijhawan, S., Kempiński, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00666-8 · Cited by 462
Khanna, R., Bressler, B., Levesque, B. G., Zou, G., Stitt, L. W., Greenberg, G. R., Panaccione, R., Bitton, A., Paré, P., Vermeire, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00068-9 · Cited by 460
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Self-citationOzanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 452
Feagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
Ananthakrishnan, A. N., Luo, C., Yajnik, V., Khalili, H., Garber, J. J., Stevens, B. W., Cleland, T., & Xavier, R. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.010 · Cited by 451
Vermeire, S., Schreiber, S., Petryka, R., Kuehbacher, T., Hebuterne, X., Roblin, X., Klopocka, M., Goldis, A., Wisniewska-Jarosinska, M., Baranovsky, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32537-5 · Cited by 439
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
Levine, A., Sigall Boneh, R., & Wine, E. (2018) · Gut · doi:10.1136/gutjnl-2017-315866 · Cited by 376
Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., Plevy, S., Popp, J., Cornillie, F. J., Lukas, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.072 · Cited by 339
Self-citationGisbert, J. P., Marín, A. C., McNicholl, A. G., & Chaparro, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13083 · Cited by 323
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease
Sandborn, W. J., Feagan, B. G., Loftus, E. V., Peyrin-Biroulet, L., Van Assche, G., D’Haens, G., Schreiber, S., Colombel, J.-F., Lewis, J. D., Ghosh, S., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.047 · Cited by 322
Papp, K. A., Gottlieb, A. B., Naldi, L., Pariser, D., Ho, V., Goyal, K., Fakharzadeh, S., Chevrier, M., Calabro, S., Langholff, W., et al. (2015) · PubMed · Cited by 312
Ungar, B., Chowers, Y., Yavzori, M., Picard, O., Fudim, E., Har-Noy, O., Kopylov, U., Eliakim, R., Ben-Horin, S., & on behalf of ABIRISK consortium (2014) · Gut · doi:10.1136/gutjnl-2013-305259 · Cited by 309
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Gordon, K. B., Duffin, K. C., Bissonnette, R., Prinz, J. C., Wasfi, Y., Li, S., Shen, Y.-K., Szapary, P., Randazzo, B., & Reich, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501646 · Cited by 306
Tillack, C., Ehmann, L. M., Friedrich, M., Laubender, R. P., Papay, P., Vogelsang, H., Stallhofer, J., Beigel, F., Bedynek, A., Wetzke, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-302853 · Cited by 302
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Schreiber, S., D’Haens, G., Tanida, S., Siffledeen, J., Enejosa, J., Zhou, W., Othman, A. A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.030 · Cited by 289
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Sands, B. E., Chen, J., Feagan, B. G., Penney, M., Rees, W. A., Danese, S., Higgins, P. D. R., Newbold, P., Faggioni, R., Patra, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.049 · Cited by 279
Schmitt, H., Billmeier, U., Dieterich, W., Rath, T., Sonnewald, S., Reid, S., Hirschmann, S., Hildner, K., Waldner, M. J., Mudter, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315671 · Cited by 261
Sandborn, W. J., Panés, J., D’Haens, G. R., Sands, B. E., Su, C., Moscariello, M., Jones, T., Pedersen, R., Friedman, G. S., Lawendy, N., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.11.035 · Cited by 248
Infliximab-Related Infusion Reactions: Systematic Review
Lichtenstein, L., Ron, Y., Kivity, S., Ben-Horin, S., Israeli, E., Fraser, G. M., Dotan, I., Chowers, Y., Confino-Cohen, R., & Weiss, B. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv096 · Cited by 239
Singh, S., Fumery, M., Sandborn, W. J., & Murad, M. H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14422 · Cited by 235
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
Sandborn, W. J., Peyrin-Biroulet, L., Zhang, J., Chiorean, M., Vermeire, S., Lee, S. D., Kühbacher, T., Yacyshyn, B., Cabell, C. H., Naik, S. U., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.035 · Cited by 235
Singh, S., Facciorusso, A., Dulai, P. S., Jairath, V., & Sandborn, W. J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.044 · Cited by 229
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
Sandborn, W. J., Ferrante, M., Bhandari, B. R., Berliba, E., Feagan, B. G., Hibi, T., Tuttle, J. L., Klekotka, P., Friedrich, S., Durante, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.043 · Cited by 229
Hedin, C. R. H., Vavricka, S. R., Stagg, A. J., Schoepfer, A., Raine, T., Puig, L., Pleyer, U., Navarini, A., van der Meulen-de Jong, A. E., Maul, J., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy191 · Cited by 226
Terdiman, J. P., Gruss, C. B., Heidelbaugh, J. J., Sultan, S., & Falck–Ytter, Y. T. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.047 · Cited by 221
Doherty, G., Katsanos, K. H., Burisch, J., Allez, M., Papamichael, K., Stallmach, A., Mao, R., Berset, I. P., Gisbert, J. P., Sebastian, S., et al. (2018) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx101 · Cited by 217
Danese, S., Sandborn, W. J., Colombel, J.-F., Vermeire, S., Glover, S. C., Rimola, J., Siegelman, J., Jones, S., Bornstein, J. D., & Feagan, B. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.038 · Cited by 216
Gisbert, J. P., Marín, A. C., & Chaparro, M. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.54 · Cited by 204
Zeissig, S., Rosati, E., Dowds, C. M., Aden, K., Bethge, J., Schulte, B., Pan, W. H., Mishra, N., Zuhayra, M., Marx, M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316023 · Cited by 203
Singh, S., Fumery, M., Sandborn, W. J., & Murad, M. H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14852 · Cited by 199
Colombel, J.-F., Adedokun, O. J., Gasink, C., Gao, L.-L., Cornillie, F. J., D'Haens, G. R., Rutgeerts, P. J., Reinisch, W., Sandborn, W. J., & Hanauer, S. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.033 · Cited by 189
Charles‐Schoeman, C., Fleischmann, R., Davignon, J., Schwartz, H., Turner, S. M., Beysen, C., Milad, M., Hellerstein, M. K., Luo, Z., Kaplan, I. V., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38974 · Cited by 188
Vermeire, S., Sandborn, W. J., Danese, S., Hébuterne, X., Salzberg, B. A., Klopocka, M., Tarabar, D., Vanasek, T., Greguš, M., Hellstern, P. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30930-3 · Cited by 188
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
Rutgeerts, P., Gasink, C., Chan, D., Lang, Y., Pollack, P., Colombel, J.-F., Wolf, D. C., Jacobstein, D., Johanns, J., Szapary, P., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.035 · Cited by 184
Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Vuitton, L., Moreau, J., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313060 · Cited by 160
Dulai, P. S., Boland, B. S., Singh, S., Chaudrey, K., Koliani‐Pace, J. L., Kochhar, G. S., Parikh, M. P., Shmidt, E., Hartke, J. G., Chilukuri, P., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.039 · Cited by 159
Cruz, P. P. D., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13353 · Cited by 147
Feagan, B. G., Sandborn, W. J., Danese, S., Wolf, D. C., Liu, W. J., Hua, S. Y., Minton, N., Olson, A. D., & D’Haens, G. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30188-6 · Cited by 142
Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis
Lee, M. J., Parker, C. E., Taylor, S. R., Guizzetti, L., Feagan, B. G., Lobo, A., & Jairath, V. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.030 · Cited by 138
Zundler, S., Schillinger, D., Fischer, A., Atreya, R. N., López-Posadas, R., Watson, A. J. M., Neufert, C. F., Atreya, I., & Neurath, M. F. (2016) · Gut · doi:10.1136/gutjnl-2016-312439 · Cited by 123
Sands, B. E., Taub, P. R., Armuzzi, A., Friedman, G. S., Moscariello, M., Lawendy, N., Pedersen, R. D., Chan, G. L., Nduaka, C. I., Quirk, D. M., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.059 · Cited by 121
Sandborn, W. J., Lee, S. D., Tarabar, D. K., Louis, E. J., Kłopocka, M., Klaus, J., Reinisch, W., Hébuterne, X., Park, D. I., Schreiber, S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313457 · Cited by 119
Schleier, L., Wiendl, M., Heidbreder, K., Binder, M.-T., Atreya, R. N., Räth, T., Becker, E., Schulz-Kuhnt, A., Stahl, A., Schulze, L. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316772 · Cited by 118
Tadbiri, S., Peyrin‐Biroulet, L., Serrero, M., Filippi, J., Pariente, B., Roblin, X., Buisson, A., Stéfanescu, C., Trang, C., Altwegg, R., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14419 · Cited by 116
Frederiksen, M. T., Ainsworth, M. A., Brynskov, J., Thomsen, O. Ø., Bendtzen, K., & Steenholdt, C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000138 · Cited by 115
Casanova, M. J., Chaparro, M., García-Sánchez, V., Nantes, Ó., Leo, E., Rojas-Feria, M., Jauregui-Amezaga, A., García‐López, S., Huguet, J. M., Argüelles‐Arias, F., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.569 · Cited by 112
Rubin, S. J. S., Bai, L., Haileselassie, Y., Garay, G., Yun, C., Becker, L. S., Streett, S. E., Sinha, S. R., & Habtezion, A. (2019) · Nature Communications · doi:10.1038/s41467-019-10387-7 · Cited by 105
Reenaers, C., Mary, J., Nachury, M., Bouhnik, Y., Laharie, D., Allez, M., Fuméry, M., Amiot, A., Savoye, G., Altwegg, R., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.061 · Cited by 99
Christensen, B., Gibson, P. R., Micić, D., Colman, R. J., Goeppinger, S. R., Kassim, O., Yarur, A. J., Weber, C. R., Cohen, R. D., & Rubin, D. T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.060 · Cited by 90
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Vermeire, S., Dreesen, E., Papamichael, K., & Dubinsky, M. C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.09.041 · Cited by 87
Feagan, B. G., Sandborn, W. J., Colombel, J., Byrne, S. O., Khalid, J. M., Kempf, C., Geransar, P., Bhayat, F., & Rubin, D. T. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy125 · Cited by 81
Uzzan, M., Tokuyama, M. A., Rosenstein, A. K., Tomescu, C., SahBandar, I. N., Ko, H. M., Leyre, L., Chokola, A., Kaplan‐Lewis, E., Rodríguez, G., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aau4711 · Cited by 79
Faleck, D. M., Winters, A. C., Chablaney, S., Shashi, P., Meserve, J. D., Weiss, A., Aniwan, S., Koliani‐Pace, J. L., Kochhar, G. S., Boland, B. S., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.040 · Cited by 77
Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease
Li, K., Friedman, J. R., Chan, D., Pollack, P., Yang, F., Jacobstein, D., Brodmerkel, C. M., Gasink, C., Feagan, B. G., Sandborn, W. J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.037 · Cited by 71
Singh, S., Dulai, P. S., Casteele, N. V., Battat, R. J., Fuméry, M., Boland, B. S., & Sandborn, W. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15484 · Cited by 70
Cited by
Ulcerative Colitis in Adults: A Review
Gros, B., & Kaplan, G. G. (2023) · JAMA · doi:10.1001/jama.2023.15389 · Cited by 738
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
Loftus, E. V., Panés, J., Lacerda, A. P., Peyrin-Biroulet, L., D’Haens, G., Panaccione, R., Reinisch, W., Louis, E., Chen, M., Nakase, H., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212728 · Cited by 483
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
D’Haens, G., Dubinsky, M., Kobayashi, T., Irving, P. M., Howaldt, S., Pokrotnieks, J., Krueger, K., Laskowski, J., Li, X., Lissoos, T., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2207940 · Cited by 361
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Verstockt, B., Salas, A., Sands, B. E., Abraham, C., Leibovitzh, H., Neurath, M. F., Vande Casteele, N., Alimentiv Translational Research Consortium (ATRC), Danese, S., D’Haens, G., et al. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00768-1 · Cited by 261
Ma, Z., Zuo, T., Frey, N., & Rangrez, A. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01946-6 · Cited by 259
Metadata
- Authors
- Baumgart, D. C., & Le Berre, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1302-1315
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3203871149
- Cited by
- 354
- References
- 98
- FWCI
- 26.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.